INHIBRX INC's ticker is INBX and the CUSIP is 45720L107. A total of 98 filers reported holding INHIBRX INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,209,396 | -12.1% | 174,899 | +24.4% | 0.00% | 0.0% |
| Q2 2023 | $3,649,691 | +88.0% | 140,589 | +36.6% | 0.00% | – |
| Q1 2023 | $1,941,666 | -91.3% | 102,897 | -88.6% | 0.00% | -100.0% |
| Q4 2022 | $22,200,197 | +22.1% | 900,982 | -11.0% | 0.00% | 0.0% |
| Q3 2022 | $18,178,000 | +279.3% | 1,012,740 | +139.9% | 0.00% | +300.0% |
| Q2 2022 | $4,792,000 | +81.5% | 422,204 | +256.3% | 0.00% | – |
| Q1 2022 | $2,640,000 | -96.0% | 118,506 | -92.1% | 0.00% | -100.0% |
| Q4 2021 | $65,484,000 | +10.1% | 1,499,524 | -16.0% | 0.01% | 0.0% |
| Q3 2021 | $59,493,000 | +0.7% | 1,786,032 | -16.8% | 0.01% | 0.0% |
| Q2 2021 | $59,063,000 | +48.9% | 2,146,195 | +8.6% | 0.01% | +42.9% |
| Q1 2021 | $39,669,000 | +10798.1% | 1,976,481 | +9683.6% | 0.01% | – |
| Q3 2020 | $364,000 | – | 20,202 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 1,023,325 | $11,615,000 | 3.23% |
| Opaleye Management Inc. | 590,000 | $6,697,000 | 3.02% |
| Sio Capital Management, LLC | 365,210 | $4,145,000 | 1.56% |
| Perceptive Advisors | 1,914,592 | $21,731,000 | 0.68% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 794,682 | $9,020,000 | 0.65% |
| Birchview Capital, LP | 70,448 | $800,000 | 0.58% |
| Meridian Wealth Advisors, LLC | 122,315 | $1,388,000 | 0.37% |
| VIKING GLOBAL INVESTORS LP | 5,305,866 | $60,222,000 | 0.28% |
| ArrowMark Colorado Holdings LLC | 1,412,236 | $16,029,000 | 0.18% |
| Alaethes Wealth LLC | 19,341 | $220,000 | 0.16% |